Form D · Biotechnology

TRINITY BIOSYSTEMS INC

Menlo Park, CA · CIK 0001186197

Offering snapshot reported Nov 13, 2009 · SEC filing

Reported sold: $7.5M
Investors reported: 17
Minimum accepted: $0
First sale: May 15, 2009

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 13, 2009	Amendment	$7,500,000	$0vs Oct 29, 2009	17	SEC filing
Oct 29, 2009	Amendment	$7,500,000	$3,500,000vs Oct 13, 2009	17	SEC filing
Oct 13, 2009	Amendment	$4,000,000	$634,541vs Jun 16, 2009	17	SEC filing
Jun 16, 2009	Initial	$3,365,459	No comparison	14	SEC filing
Jun 2, 2006	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Not reported
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-47911

Source: Form D, filed Nov 13, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Michael C. Diem	Director
Amin Khan	Director, Executive
Helen Kim	Director
Rene Kuijten	Director, Executive
Gail Maderis	Director
Peter C. Mc Williams	Director
S. Edward Torres	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

1490 O'brien Avenue
Menlo Park, CA, 94025